From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. - Wikidata - awgldk - TriplyDB

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

http://www.wikidata.org/entity/Q38142595

about

Macrophages Subvert Adaptive Immunity to Urinary Tract Infection Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges Cancer and the microbiota.Innate immunity and genetic determinants of urinary tract infection susceptibility.Microbiome, a new dimension in cancer research Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.The nature of immune responses to urinary tract infections Future directions in bladder cancer immunotherapy: towards adaptive immunity.Effect of Preoperative Bacteriuria and Pyuria on Intravesical Recurrence in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.Pathogenesis of Proteus mirabilis Infection.

P2860

Q27318440-C8133035-43A2-49E3-BD09-C3C8A80B9372 Q34297628-5ABDCEA5-DCF3-4CDC-9D07-F36B31E2334B Q34470083-D9634B70-055B-49D3-89D2-FF8834B1C929 Q34856462-2EAB336D-9882-4CED-8126-23DB3DF2B4DF Q36138105-B765B8F5-BA49-47FD-9776-3BDC14EC4F47 Q36161576-030C64F7-642E-49B0-B2CA-DBBA2D98FB5F Q37050386-BCCE4F96-0B2A-45D7-BD1B-7C53E3193F50 Q38727522-E27E18D3-9E7B-46E2-A25C-A29D9A83469C Q49537526-FC9B5685-88D9-4D8D-AC12-61BC094D8582 Q50102491-84685CC7-BFF1-4F4A-8AB5-4CF08DDBA1A1

P2860

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

http://www.wikidata.org/entity/Q38142595

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

@en

type

label

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

@en

prefLabel

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

@en

P1433

Q38142595-17824571-9003-4D1A-B1A4-F4C8B734712A

P1476

Q38142595-A26079E5-FE49-4266-AFF3-DCE6287E2865

P2093

Q38142595-ACEEE819-7F16-4918-8C78-205D3A32FA6E

Q38142595-E95F96B4-801C-4A53-ADA3-1EF939AD8E7C

P2860

Q38142595-0088E891-FAD0-4B25-91EA-1E467EE478DA

Q38142595-0277BB58-1A2F-4CFE-AB44-4C03B27ABD2F

Q38142595-0450ADDD-E78F-47FF-8F9E-5A86D8BFA317

Q38142595-0CA6E28C-6B97-4245-906A-F8A0731BB000

Q38142595-10297107-05DE-4DF9-BACD-B6F5E66044CA

Q38142595-11360CC9-BD91-4573-9DA8-3DE1E1683598

Q38142595-12DC754D-981D-4E73-A163-E3E29B816EDF

Q38142595-159C3C0F-EA3A-4506-8718-7BCF3A18FAD3

Q38142595-1D05E450-5A22-4F5F-B835-F91C4AEBC5FF

Q38142595-2289D8EE-328B-4C49-8AF0-33BCE63A8F86

P2888

Q38142595-1C5E51F8-1C09-4FE2-BA43-176CFA71E08D

P304

Q38142595-1A31C251-CDE7-4E1E-8521-31C679EB6EE9

P31

Q38142595-FBA2974D-B9B4-41F9-8E26-64839A8E11C0

P356

Q38142595-BD17A2ED-9DC8-4361-844B-761F10810D58

P433

Q38142595-C0B481F2-8A5E-47FF-889C-02D533E46AEE

P478

Q38142595-6112052F-63A8-47B0-815F-D42C454C1FFE

P577

Q38142595-0C7C5CC5-1073-481D-B2EC-70AD7C41A768

P5875

Q38142595-9BCD5723-F59C-4E45-9709-8878121DACBA

P6179

Q38142595-977B0121-BDCD-4636-A7C9-91F641BCCDA8

P698

Q38142595-0010BA23-1726-4F52-9F42-1FF10CB957CE

P921

Q38142595-FC549C83-C4EF-4366-A4E3-7B7A6E851C75

P356

P1433

Mucosal Immunology

P1476

From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.

@en

P2093

M A Ingersoll

http://www.w3.org/2001/XMLSchema#string

M L Albert

http://www.w3.org/2001/XMLSchema#string

P2860

Human beta-defensin-1: an antimicrobial peptide of urogenital tissues

Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection

Cancer statistics, 2013

Bacterial adhesion to target cells enhanced by shear force

Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection

Vaginal microbiome of reproductive-age women.

Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection

A toll-like receptor that prevents infection by uropathogenic bacteria

Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability

P2888

P304

1041-1053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MI.2013.72

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257071260

http://www.w3.org/2001/XMLSchema#string

P6179

1030524243

http://www.w3.org/2001/XMLSchema#string

P698

24064671

http://www.w3.org/2001/XMLSchema#string

P921